Pharmacy & Therapeutics Update: Drug Information for Health Care Professionals, February 2006

https://medica-musc.researchcommons.org/musc-ptupdate/1019/thumbnail.jp

Pharmacy & Therapeutics Update: Drug Information for Health Care Professionals

https://medica-musc.researchcommons.org/musc-ptupdate/1018/thumbnail.jp

Pharmacy & Therapeutics Update: Drug Information for Health Care Professionals, March/April 2006

https://medica-musc.researchcommons.org/musc-ptupdate/1021/thumbnail.jp

Pharmacy & Therapeutics Update: Drug Information for Health Care Professionals, June 2006

https://medica-musc.researchcommons.org/musc-ptupdate/1023/thumbnail.jp

Pharmacy & Therapeutics Update: Drug Information for Health Care Professionals

https://medica-musc.researchcommons.org/musc-ptupdate/1019/thumbnail.jp

Pharmacy & Therapeutics Update: Drug Information for Health Care Professionals

https://medica-musc.researchcommons.org/musc-ptupdate/1022/thumbnail.jp

Pharmacy & Therapeutics Update: Drug Information for Health Care Professionals

https://medica-musc.researchcommons.org/musc-ptupdate/1021/thumbnail.jp

Pharmacy & Therapeutics Update: Drug Information for Health Care Professionals

https://medica-musc.researchcommons.org/musc-ptupdate/1023/thumbnail.jp

Pharmacy & Therapeutics Update: Drug Information for Health Care Professionals

https://medica-musc.researchcommons.org/musc-ptupdate/1020/thumbnail.jp

Clinical Features and Associated Likelihood of Primary Ciliary Dyskinesia in Children and Adolescents

Rationale: Primary ciliary dyskinesia (PCD), a genetically heterogeneous, recessive disorder of motile cilia, is associated with distinct clinical features. Diagnostic tests, including ultrastructural analysis of cilia, nasal nitric oxide measurements, and molecular testing for mutations in PCD genes, have inherent limitations